🇫🇷 FR 🇬🇧 EN 🇮🇹 IT 🇩🇪 DE 🇳🇱 NL 🇪🇸 ES 🇮🇱 HE 🇸🇦 AR
Cochin Hospital – Port-Royal · AP-HP · Paris Cité University
← Interventional Radiology
Interventional Radiology Cochin
Cochin Hospital AP-HP AP-HP

Desmoid Tumours

Interventional Radiology · Cochin Hospital AP-HP · Paris

🧬 Desmoid tumours — National reference centre

Desmoid Tumours — Cryoablation & Chemoembolization

National reference centre · Percutaneous treatment · Clinical trial open

🏆 Our department is a national reference centre in France for the interventional radiology management of desmoid tumours. We offer two complementary approaches: percutaneous cryoablation and doxorubicin chemoembolization.

What are desmoid tumours?

Desmoid tumours (aggressive fibromatosis) are rare tumours of fibrous tissue, locally invasive but non-metastatic. They can arise in the abdominal wall, mesentery, muscles, extremities or trunk. Their behaviour is unpredictable: some regress spontaneously, others progress rapidly and recur after surgery.

Management is now multidisciplinary, with a trend towards active surveillance for stable tumours and minimally invasive percutaneous treatment for symptomatic or progressive disease.

1 — Percutaneous cryoablation

Indication: Symptomatic or progressive desmoid tumours accessible via a percutaneous approach, regardless of location (abdominal wall, limbs, mesentery, pelvis).

  • Destroys tumour cells through extreme cold (−40°C to −160°C) without open surgery
  • CT-guided, under general anaesthesia for larger lesions
  • Can be repeated if needed
  • Published results in major international journals
Note on MRI interpretation: Post-cryoablation MRI at 3 months often shows a pseudo-progression (inflammatory reaction) — this does not indicate treatment failure. Assessment should be deferred to 6 months.

2 — Doxorubicin chemoembolization

Indication: Desmoid tumours supplied by identifiable feeding arteries — particularly limb, abdominal wall and trunk lesions.

  • Targeted delivery of doxorubicin directly into the tumour vasculature
  • Combined chemotherapy and embolization effect
  • Currently being evaluated within a prospective clinical trial
  • Performed under local anaesthesia or light sedation

Clinical trial

🔬 Open clinical trial — Our team is currently recruiting patients for a prospective evaluation of chemoembolization in desmoid tumours. If you wish to be considered, please contact us at ri.cch@aphp.fr.

At a glance — key figures

Desmoid tumours are rare, locally aggressive soft-tissue tumours treated by cryoablation or chemoembolization, preserving surrounding tissue and avoiding mutilating surgery.

CriterionData
BehaviourLocally aggressive but does not metastasise to other organs
Active surveillanceA recognised strategy — some tumours stabilise or regress spontaneously
CryoablationDestroys the tumour with cold through needles under imaging guidance, tissue-sparing
Decision-makingMade in a specialist multidisciplinary setting
CostCovered by French national health insurance at Cochin AP-HP — no out-of-pocket fees.

Data validated by the team of Prof. Anthony Dohan, Department of Interventional Radiology, Cochin Hospital AP-HP, Université Paris Cité.

Frequently asked questions

Can desmoid tumours be cured by cryoablation?
Cryoablation can achieve local tumour control in many patients. Marginal recurrences are possible and can be treated with a further session. The goal is long-term tumour stabilisation and symptom relief rather than definitive cure in all cases.
What if I have already tried medical treatment (sulindac, sorafenib, imatinib)?
Percutaneous treatment can be considered after failure or intolerance to systemic medical therapy. The decision is always discussed in a multidisciplinary tumour board.
What are desmoid tumours?
Desmoid tumours are rare, locally aggressive soft-tissue tumours that do not spread to other organs but can grow into surrounding structures and cause pain and functional problems.
How does interventional radiology treat them?
Cryoablation destroys the tumour with cold through needles placed under imaging guidance, and chemoembolization can be used for selected lesions. Both preserve surrounding tissue and avoid mutilating surgery.
Is surveillance sometimes preferred?
Yes. Some desmoid tumours stabilise or even regress spontaneously, so active surveillance is a recognised strategy. Treatment is reserved for growing or symptomatic tumours, and decisions are made in a specialist multidisciplinary setting.
Is it covered by insurance?
Yes. At Cochin AP-HP (a French public hospital), this procedure is covered by national health insurance with no out-of-pocket fees. Contact ri.cch@aphp.fr or +33 1 58 41 46 12.

📄 Patient information leaflet: Download PDF →

Covered by French health insurance (Assurance Maladie). No extra fees at Cochin Hospital AP-HP.

Why this page is trustworthy

Written by the Interventional Radiology team at Cochin Hospital AP-HP, Université Paris Cité. Medically reviewed by an interventional radiologist of the department. Last updated: August 2026.

🏥 Le service 📰 Actualités 🔬 Recherche & essais cliniques